Patient Advocacy Leadership Award (PAL Award)
In honor of International Rare Disease Day held February 29th, Genzyme is pleased to announce the 2012 Patient Advocacy Leadership Award (PAL Awards) program for LSD patient organizations worldwide. As you may know, more than 50 patient organizations around the world submitted applications last year, making it a very competitive and successful program.
The PAL Awards program seeks to encourage patient organizations around the world to develop bold ideas and programs to improve disease awareness, patient education, care and support through a competitive grants process. This program highlights Genzyme's on-going commitment to the rare disease community and continuing collaboration with LSD patient organizations worldwide. With the PAL Awards, we hope to increase awareness of rare diseases and ultimately improve the lives of patients living with lysosomal storage disorders.